Analysts Viewpoint Syndax Pharmaceuticals Inc [SNDX] Investment Appeal on the Rise In a filing, Syndax Pharmaceuticals Inc revealed its Head of R&D, CMO Botwood Nicholas A.J. acquired Company’s shares for reported
Featured Why Syndax Pharmaceuticals Inc. (SNDX) stock is decreasing rapidly? Syndax Pharmaceuticals, Inc. (SNDX), a clinical-stage healthcare company that focuses on an HDAC inhibitor for tumors and specializes in cancer